Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells. | Open Life Sci | 2023 | 37724115 | PubTator, text mining | PubMed |
| CTNNAL1 deficiency suppresses CFTR expression in HDM-induced asthma mouse model through ROCK1-CAL signaling pathway. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37715489 | PubTator, text mining | PubMed |
| Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis. | J Clin Invest | 2023 | 37712420 | PubTator, text mining | PubMed |
| Y-27632 acts beyond ROCK inhibition to maintain epidermal stem-like cells in culture. | J Cell Sci | 2023 | 37698512 | PubTator, text mining | PubMed |
| Flourishing tumor organoids: History, emerging technology, and application. | Bioeng Transl Med | 2023 | 37693042 | PubTator, text mining | PubMed |
| Challenges and Future Trends in the Treatment of Psoriasis. | Int J Mol Sci | 2023 | 37686119 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. | Commun Biol | 2023 | 37684337 | PubTator, text mining | PubMed |
| Stromal cells in the tumor microenvironment: accomplices of tumor progression? | Cell Death Dis | 2023 | 37666813 | PubTator, text mining | PubMed |
| How many kinases are druggable? A review of our current understanding. | Biochem J | 2023 | 37642371 | PubTator, text mining | PubMed |
| Research Progress and Molecular Mechanisms of Endothelial Cells Inflammation in Vascular-Related Diseases. | J Inflamm Res | 2023 | 37641702 | PubTator, text mining | PubMed |
| Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases. | Pharmaceuticals (Basel) | 2023 | 37630974 | PubTator, text mining | PubMed |
| Role of Circular RNAs in Atherosclerosis through Regulation of Inflammation, Cell Proliferation, Migration, and Apoptosis: Focus on Atherosclerotic Cerebrovascular Disease. | Medicina (Kaunas) | 2023 | 37629751 | PubTator, text mining | PubMed |
| Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles. | Int J Mol Sci | 2023 | 37629204 | PubTator, text mining | PubMed |
| The Role of microRNAs in Epigenetic Regulation of Signaling Pathways in Neurological Pathologies. | Int J Mol Sci | 2023 | 37629078 | PubTator, text mining | PubMed |
| Exploring New Therapeutic Avenues for Ophthalmic Disorders: Glaucoma-Related Molecular Docking Evaluation and Bibliometric Analysis for Improved Management of Ocular Diseases. | Bioengineering (Basel) | 2023 | 37627868 | PubTator, text mining | PubMed |
| Stress Factors as Possible Regulators of Pluripotent Stem Cell Survival and Differentiation. | Biology (Basel) | 2023 | 37627003 | PubTator, text mining | PubMed |
| The Activation of the LIMK/Cofilin Signaling Pathway via Extracellular Matrix-Integrin Interactions Is Critical for the Generation of Mature and Vascularized Cardiac Organoids. | Cells | 2023 | 37626839 | PubTator, text mining | PubMed |
| Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies. | Noncoding RNA | 2023 | 37624036 | PubTator, text mining | PubMed |
| Gene Expressions Preferentially Influence Cortical Thickness of Human Connectome Project Atlas Parcellated Regions in First-Episode Antipsychotic-Naïve Psychoses. | Schizophr Bull Open | 2023 | 37621304 | PubTator, text mining | PubMed |
| Biofabrication of functional bone tissue: defining tissue-engineered scaffolds from nature. | Front Bioeng Biotechnol | 2023 | 37614632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=19